Effects of an acute dose of L-Arginine during coronary angiography in patients with chronic renal failure: A randomized, parallel, double-blind clinical trial

American Journal of Nephrology

Volumn 23, Issue 2, 2003, Pages 91-95

  Miller, Hylton I ^a   Dascalu, Avi ^a   Rassin, Tovy A ^a   Wollman, Y ^a   Chernichowsky, T ^a   Iaina, A ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Angiography; Contrast media; L Arginine; Renal failure

Indexed keywords

ARGININE; CREATININE; MEGLUMINE IOXAGLATE; NITRIC OXIDE; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART HEMODYNAMICS; HEART OUTPUT; HUMAN; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; VASCULAR RESISTANCE;

AGED; ANALYSIS OF VARIANCE; ARGININE; BLOOD PRESSURE; CARDIAC OUTPUT; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CREATININE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; NITRIC OXIDE; VASCULAR RESISTANCE;

EID: 0037258184     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068036     Document Type: Article

References (33)

1. Baroldi G: Different morphological types of myocardial cell death in man. Rec Adv Stud Cardiac Struct Metab 1975;6:383-397.
2. Berg KJ: Nephrotoxicity related to contrast media. Scand J Urol Nephrol 2000;34:317-322.
3. Blum M, Yachnin T, Wollman Y, Chernihovsky T, Peer G, Grosskopf I, Kaplan E, Silverberg D, Cabili S, Iaina A: Low nitric oxide production in patients with chronic renal failure. Nephron 1998;79:265-268.
4. Boger RH, Bode-Boger SM: The clinical pharmacology of L-arginine. (review). Ann Rev Pharmacol Toxicol 2001;41:79-99.
5. Boger RH, Bode B: Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost 2000;26:539-545.
6. Boger RH, Bode B: The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001;41:79-99.
7. Chiang ML, Hawkins EP, Berry PL, Barrish J, Hill LL: Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: An ultrastructural study. Clin Nephrol 1988;30:8-14.
8. Cross JM, Donald AE, Kharbanda R, Deanfield JE, Woolfson RG, MacAllister RJ: Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure. Kidney Int 2001;60:2318-2323.
9. Dascalu A, Peer A: Effects of radiologic contrast media on human endothelial and kidney cell lines: Intracellular pH and cytotoxicity. Acad Radiol 1994;1:145-150.
10. De N, Bellizzi V, Minutolo R, Andreucci M, Capuano A, Garibotto G, Corso G, Andreucci VE, Cianciaruso B: Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure. Kidney Int 1999;56:674-684.
11. Donadio C, Lucchesi A, Ardini M, Tramonti G, Chella P, Magagnini E, Bianchi C: Renal effects of cardiac angiography with different low-osmolar contrast media. Ren Fail 23:385-396.
12. Duan SB, Wu HW, Luo JA, Liu FY: Assessment of renal function in the early stages of nephrotoxicity induced by iodinated contrast media. Nephron 1999;83:122-125.
13. Fujita H, Yamabe H, Yokoyama M: Effect of L-arginine administration on myocardial thallium-201 perfusion during exercise in patients with angina pectoris and normal coronary angiograms. J Nucl Cardiol 2000;7:97-102.
14. Goumas G, Tentolouris C, Tousoulis D, Stefanadis C, Toutouzas P: Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases. Atherosclerosis 2001;154: 255-267.
15. Hardiek K, Katholi RE, Ramkumar V, Deitrick C: Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol 2001;280:F61-F70.
16. Heyman SN, Goldfarb M, Carmeli F, Shina A, Rahmilewitz D, Brezis M: Effect of radiocontrast agents on intrarenal nitric oxide (NO) and NO synthase activity. Exp Nephrol 1998;6:557-562.
17. Hutcheson IR, Griffith TM, Pitman MR, Towart R, Gregersen M, Refsum H, Karlsson JO: Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. Br J Pharmacol 1999;128:451-457.
18. Kanaya Y, Nakamura M, Kobayashi N, Hiramori K: Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure. Heart 1999; 81:512-517.
19. Klahr S: Can L-arginine manipulation reduce renal disease? Semin Nephrol 1999;19:304-309.
20. Morcos SK: Contrast media-induced nephrotoxicity - questions and answers. Br J Radiol 1998;71:357-365.
21. Morcos SK, Dawson P, Pearson JD, Jeremy JY, Davenport AP, Yates MS, Tirone P, Cipolla P, de H, Muschick P, Krause W, Refsum H, Emery CJ, Liss P, Nygren A, Haylor J, Pugh ND, Karlsson JO: The haemodynamic effects of iodinated water soluble radiographic contrast media: A review. Eur J Radiol 1998;29:31-46.
22. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: A prospective controlled study. N Engl J Med 1989;320:143-149.
23. Penttinen J, Pennanen S, Liesivuori J: Indicators of L-arginine metabolism and cardiovascular risk factors: A cross-sectional study in healthy middle-aged men. Amino Acids 2000;18:199-206.
24. Potier M, Lagroye I, Lakhdar B, Cambar J, Idee JM: Comparative cytotoxicity of low- and high-osmolar contrast media to human fibroblasts and rat mesangial cells in culture. Invest Radiol 1997;32:621-626.
25. Reckelhoff JF, Kellum JA, Racusen LC, Hildebrandt DA: Long-term dietary supplementation with L-arginine prevents age-related reduction in renal function. Am J Physiol 1997; 272:R1768-R1774.
26. Schlaich MP, Jacobi J, John S, Delles C, Fleischmann I, Schmieder RE: Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature? Clin Sci (Colch) 2000;99:293-302.
27. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM: Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989;320:149-153.
28. Schwartz D, Blum M, Peer G, Wollman Y, Maree A, Serban I, Grosskopf I, Cabili S, Levo Y, Iaina A: Role of nitric oxide (EDRF) in radiocontrast acute renal failure in rats. Am J Physiol 1994;267:F374-F379.
29. Solomon R, Werner C, Mann D, Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
30. Tepel M, van d, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343:180-184.
31. Tervahartiala P, Kivisaari L, Kivisaari R, Vehmas T, Virtanen I: Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron 1997;76:96-102.
32. Xiao S, Wagner L, Mahaney J, Baylis C: Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells. Am J Physiol Renal Physiol 1901;280:F989-F995.
33. Zhang H, Holt CM, Malik N, Shepherd L, Morcos SK: Effects of radiographic contrast media on proliferation and apoptosis of human vascular endothelial cells. Br J Radiol 2000;73:1034-1041.